“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Carbonic anhydrase inhibitors: Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides—in vitro and in vivo studies

Carbonic anhydrase inhibitors: Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides—in vitro and in vivo studies Malaria, a major parasitic disease of humans, is caused by protozoa of the genus Plasmodium , classified in the phylum Apicomplexa. 1 The disease afflicts 515 million and kills 1.5–2.7 million people each year, most of whom children in sub-Saharan Africa. 2–6 P. falciparum is responsible for most of these deaths. 2,6 In addition to the lack of effective vector control and vaccines, the limitations and toxicity of antimalarial drugs in current use, and the spread of drug-resistant malaria accompanied by a worldwide resurgence of the disease, highlights the need to develop quickly more effective and less toxic novel antimalarial drugs, possessing a different mechanism of action. 5,7–10 Drug screening procedures have rarely been applied to identify lead molecules for this disease, and there is a paucity of information on a number of metabolic pathways that can be exploited for malaria chemotherapy. 7–9 A better understanding of biochemical differences between the parasite and human metabolic processes may provide new targets for intervention in the fight against this disease. 10 In 1998, Sein and Aikawa 11 proved the in situ carbonic anhydrase (CA, EC 4.2.1.1) activity in P. falciparum -infected red blood cells by using electron microscopy and CA-specific http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bioorganic & Medicinal Chemistry Letters Elsevier
Loading next page...
 
/lp/elsevier/carbonic-anhydrase-inhibitors-inhibition-of-plasmodium-falciparum-wUWk7gBmf5

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.